• New Cortisol Analysis Test Offers Faster, More Accurate Diagnosis

    Apr 11 | Diagnostics World | As the body’s stress hormone, cortisol influences several diseases, from chronic illnesses, such as diabetes and cancer; to mental illnesses, such as depression; to neurological diseases, such as Alzheimer’s disease. Researchers at Aarhus University have discovered a breakthrough method to measure cortisol in an efficient, faster way. More
  • NVIDIA GTC Panel Explores the Role of Generative AI in Medicine

    Apr 09 | Diagnostics World | During the NVIDIA GTC conference held at the San Jose Convention Center and online March 18-21, NVIDIA CEO Jensen Huang highlighted an array of advancements, including new foundation models coming to NVIDIA BioNeMo, a collaboration with Johnson & Johnson MedTech to expand AI’s role in surgical settings, and the launch of over two dozen generative AI microservices to advance areas like digital health, medical technology, and drug discovery. More
  • Time-Of-Day Activity Levels Linked To Amyloid Deposits In The Brain

    Apr 04 | Diagnostics World | A wearable device measuring movement at the wrist can detect clear differences in people who do and don’t have beta-amyloid deposition in their brain. The discovery was enabled by a relatively new statistical technique revealing time-of-day changes in activity levels not captured by standard methods focused on average levels of activity across the day. More
  • EEG Monitoring Concerningly Underutilized In Clinical Trials

    Apr 03 | Diagnostics World | Study sponsors making choices about if, when, and how to include brain monitoring in their clinical studies do not often ground those choices in science or optimize for subject safety and trial de-risking. The key problem is a lack of electroencephalogram (EEG) expertise with no guidance from the Food and Drug Administration (FDA) to mitigate the situation. More
  • Outlook Good for Cancer Diagnostic Industry, Says Panel

    Apr 02 | Diagnostics World | You might be forgiven for calling the tone of a panel on diagnostics held at last week’s Precision Medicine Tri-Con “optimistic”. But you would be corrected: it isn’t optimism, it’s math. More
  • Johns Hopkins University Develops COVID-19 Detection Tool, Fluid Biomarker, Bayer AG Collaborates With Thermo Fisher Scientific, More

    Mar 27 | Diagnostics World | Capstan Therapeutics is advancing CPTX2309, their lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, to early clinical proof-of-concept in autoimmune disorders; Clasp is developing modular T cell engagers tailored to each patient’s immune system that are directed to common oncogenic driver mutations; X-Therma plan to scale global commercial operations and facilitate progression into the clinical stage with FDA Breakthrough Device status, aimed at significantly increasing organ availability for transplantation by overcoming time-sensitive limitations; and more. More
  • Follow the Money: In Vivo CAR-T Candidate Development, Developing Modular TCEs, Increasing Organ Availability, More

    Mar 26 | Diagnostics World | Capstan Therapeutics is advancing CPTX2309, their lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, to early clinical proof-of-concept in autoimmune disorders; Clasp is developing modular T cell engagers tailored to each patient’s immune system that are directed to common oncogenic driver mutations; X-Therma plan to scale global commercial operations and facilitate progression into the clinical stage with FDA Breakthrough Device status, aimed at significantly increasing organ availability for transplantation by overcoming time-sensitive limitations; and more. More
  • RNA-Protein Complex Contributing To ‘Background Autoimmunity’ In Women

    Mar 21 | Diagnostics World | The single biggest risk factor for autoimmune disease is being biologically a female and many explanations have been proposed as to why that is, among them sex hormones and the X chromosome with its large number of immune-related genes. More
  • Citizen-Driven Research Aids Development Of Digital Biomarkers For ALS

    Mar 20 | Diagnostics World | When it comes to research on amyotrophic lateral sclerosis (ALS), every stakeholder—most especially patients—knows time is of the essence. From diagnosis to death, life expectancy from the debilitating neuromuscular disease can be two years or less. More
  • Trial Begins For ‘Probabilistic Approach’ To Diagnosing Ovarian Cancer

    Mar 19 | Diagnostics World | Scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) are proposing a new, more realistic approach to diagnosing cancer that provides a probabilistic statement about the likelihood of developing it, much like how cholesterol tests are used to assess heart disease risk. Probabilities are based on an individual’s metabolic profile and the first population group to be targeted are women at high risk for ovarian cancer. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more